title: Serum levels of anti-hepatitis C virus IgM core antibodies may predict the response to interferon-alpha therapy in chronic hepatitis C.
abstract: We measured the optical densities (OD) of serum anti-hepatitis C virus IgM core antibodies in 40 HCV-positive patients (24 males and 16 females) with histologically proven chronic active hepatitis but without cirrhosis. All patients were treated with i.m. injections of 3 MU thrice weekly of interferon-alpha (IFN-alpha) for 6 months and followed-up monthly. Optical densities were evaluated in thawed sera before beginning treatment and 6 months after completion, and in fresh sera obtained at the end of an 8-12-month follow-up period. Patients were grouped into three categories according to the OD obtained: < 0.3 (negative test); 0.3-0.6 (intermediate positivity); > 0.6 (high positivity). According to the response to treatment during the follow-up period, patients were further divided into three classes: sustained responders; relapsers or partial responders; non-responders. In each patient, the OD values were similar in the three determinations before, after therapy and at the end of the follow-up period. All patients with an intermediate positive test for anti-HCV IgM core antibodies were relapsers or partial responders, and all patients with high OD values were non-responders. Conversely, 71% of the patients with a negative test were sustained responders. We conclude that this cheap and easily performed test may be useful in predicting the response to IFN therapy.
authors.affiliation: Division of Gastroenterology, Ospedale Mauriziano Umberto I di Torino, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Tabone
authors.forename: G
authors.initials: G
authors.lastname: Galatola
authors.forename: P
authors.initials: P
authors.lastname: Secreto
authors.forename: C
authors.initials: C
authors.lastname: Marini
authors.forename: G
authors.initials: G
authors.lastname: Molinaro
authors.forename: S
authors.initials: S
authors.lastname: Aricò'
mesh_terms: D000328:Adult; D002908:Chronic Disease; D005260:Female; D006526:Hepatitis C / Q000276:immunology / Q000628:therapy*; D018937:Hepatitis C Antibodies / Q000097:blood*; D006801:Humans; D007075:Immunoglobulin M / Q000097:blood*; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged
chemical_list: D018937:Hepatitis C Antibodies; D007075:Immunoglobulin M; D016898:Interferon-alpha